Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Plant extracts >  Plant Extracts >  2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol

Basic information Safety Supplier Related

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Basic information

Product Name:
2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol
Synonyms:
  • 2-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol
  • 2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol
  • Gnetol
  • 2,3',5',6-Tetrahydroxy-trans-stilbene
  • -2-(3,5-Dihydroxystyryl)
  • Gnetol>
  • (E)-2-(3,5-Dihydroxystyryl)benzene-1,3-diol
  • 1,3-Benzenediol, 2-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]-
CAS:
86361-55-9
MF:
C14H12O4
MW:
244.24
EINECS:
617-839-9
Mol File:
86361-55-9.mol
More
Less

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Chemical Properties

Melting point:
271°C(lit.)
Boiling point:
540.8±30.0 °C(Predicted)
Density 
1.468±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
form 
powder to crystal
pka
9.06±0.40(Predicted)
color 
White to Light yellow to Light orange
λmax
337nm(EtOH)(lit.)
CAS DataBase Reference
86361-55-9
More
Less

Safety Information

HS Code 
2907.29.9000
More
Less

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol Usage And Synthesis

Uses

Gnetol (cas# 86361-55-9) is a compound useful in organic synthesis.

in vivo

Male Sprague-Dawley rats were cannulated and dosed either intravenously with Gnetol (10μg/kg) or orally (100mg/kg). After oral and intravenous administration, Gnetol is detected in both serum and urine as the parent compound and as a glucuronidated metabolite. The bioavailability of Gnetol is determined to be 6%. Gnetol is rapidly glucuronidated and is excreted in urine and via nonrenal routes[1].
Pretreatment of Male NIH Swiss mice (20-35 g) with Gnetol (50mg/kg, SC) is able to increase the latency period to response in analgesia models[1].

target

Tyrosinase | BACE

IC 50

COX-1: 0.78 μM (IC50); Tyrosinase: 4.5 μM (IC50); HDAC

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediolSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
BioBioPha Co., Ltd.
Tel
0871-65217109 13211707573;
Email
y.liu@mail.biobiopha.com
TOKYO CHEMICAL INDUSTRY CO., LTD.
Tel
03-36680489
Email
Sales-JP@TCIchemicals.com
More
Less

2-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,3-benzenediol(86361-55-9)Related Product Information